Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Solara Active Pharma Sciences Ltd.
₹523.20
₹520.10
₹553.00
₹422.00
₹734.40
Markets Today
Historical Performance
As of 08-06-2026 20:16, Solara Active Pharma Sciences Ltd. share price today is ₹0, with a change of ₹-534.85 (-100.00%) from the previous close of ₹534.85. The stock opened at ₹536 and traded between ₹520.1 and ₹553, with a total traded volume of 126380 shares. The company has a market capitalization of ₹2518.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹734.4 and ₹422, respectively.
Solara Active Pharma Sciences Ltd. valuation metrics include a P/E ratio of -339.9, EPS of ₹-1.68, and book value of ₹2.00. Profitability indicators show ROE of -0.59%. Solara Active Pharma Sciences Ltd. has reported revenue of ₹1368.98 Cr and net profit of ₹-7.41 Cr.
Solara Active Pharma Sciences Ltd. technical indicators include Day RSI at 50.98, Day MFI at 67.29, Day ADX at 43.36. Additional indicators include Commodity Channel Index (CCI) at -20.7 and Williams %R at -87.9. Momentum indicators show Day MACD at 9.72, Day MACD Signal Line at 13.99, DayATR at 26.31. Rate of Change indicators for Solara Active Pharma Sciences Ltd. include ROC125 at 2.86 and ROC21 at 4.3.
Exponential moving averages include EMA5 at ₹540.5, EMA10 at ₹542.8, EMA12 at ₹542.6, EMA20 at ₹537.8, EMA26 at ₹532.9, EMA50 at ₹518.6, EMA100 at ₹516.7, EMA200 at ₹532.8. Simple moving averages include SMA5 at ₹541.5, SMA10 at ₹544.7, SMA20 at ₹544, SMA30 at ₹528.4, SMA50 at ₹505.2, SMA100 at ₹499.3, SMA150 at ₹522, SMA200 at ₹548.8.
Support levels for Solara Active Pharma are placed at First Support ₹526.83, Second Support ₹518.82, Third Support ₹505.63. Resistance levels are seen at First Resistance ₹548.03, Second Resistance ₹561.22, Third Resistance ₹569.23. Solara Active Pharma Sciences Ltd. shareholding pattern shows promoter holding at 42%, FII holding at 11.59%, DII holding at 0%, public holding at 42.66%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 387.29 | 349 | 313.54 | 319.15 | 273.01 |
| Operating Expense | 329.74 | 311.65 | 278.79 | 262.12 | 230.42 |
| Operating Profit | 57.55 | 37.35 | 34.75 | 57.03 | 42.59 |
| Depreciation | 26.04 | 25.57 | 24.49 | 23.58 | 24.30 |
| Interest | 27.06 | 22.45 | 20.83 | 23.90 | 29.12 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 9.73 | -17.42 | -10.08 | 10.53 | -4.88 |
₹523.20
↗ Bullish Moving Average
5
↘ Bearish Moving Average
11
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 37.2 | 37.9 | 42 | 42 | 42 | 42 |
| FII | 14.7 | 14.6 | 14.2 | 13.6 | 12 | 11.6 |
| DII | 3.2 | 2.6 | 2.7 | 2.7 | 3.6 | 3.7 |
| Public | 44.9 | 44.8 | 41.1 | 41.7 | 42.4 | 42.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 46.65 K | 1.05 L | 44.37% |
| Week | 59.62 K | 1.64 L | 36.26% |
| 1 Month | 87.81 K | 3.79 L | 23.14% |
| 6 Month | 52.88 K | 1.83 L | 28.95% |
Companies with 10% increase in share price over three months, with rising net profit growth
Relative Outperformance versus Industry over 1 Month
Turnaround Companies: Loss to Profit QoQ
Expensive Performers (DVM)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Turnaround companies- loss to profit QoQ
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing Revenue every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Aug, 2021 | 3 | FINAL | Equity Share | |
| 19 Nov, 2020 | 4 | INTERIM | 20 Nov, 2020 | Equity Share |
| 28 Jul, 2020 | 2 | FINAL | Equity Share | |
| 06 Aug, 2019 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹126 | ₹550.90 | ₹6.14 | ₹108 | ₹131.65 | ₹14.15 |
| % Change | N/A | 1.05% | -3.91% | -3.57% | -1.38% | 1.22% |
| Revenue TTM (₹ Cr) | - | - | ₹83.60 | - | ₹287.68 | ₹176.50 |
| Net Profit TTM (₹ Cr) | - | - | ₹-34.95 | - | ₹14.88 | ₹27.81 |
| PE TTM | 61.50 | - | -1.50 | 12.90 | 34.20 | 26.90 |
| 1 Year Return | -7.48 | 40.54 | 523 | -14.06 | 3.85 | 54.51 |
| ROCE | - | 3.56 | -5.63 | - | - | 17.36 |
Medistep Healthcare Ltd.
₹ 19.55
+0.00%
Influx Healthtech Ltd.
₹ 233.00
-2.51%
Medicamen Organics Ltd.
₹ 21.00
+0.00%
Amrutanjan Health Care Ltd.
₹ 552.20
+0.03%
Senores Pharmaceuticals Ltd.
₹ 1001.10
-3.25%
Innova Captab Ltd.
₹ 866.90
-0.07%
Valiant Laboratories Ltd.
₹ 72.40
-1.03%
Sigachi Industries Ltd.
₹ 21.07
-1.86%
Windlas Biotech Ltd.
₹ 801.10
-1.60%
Vineet Laboratories Ltd.
₹ 33.95
-2.36%
Zim Laboratories Ltd.
₹ 107.50
+2.26%
Medico Remedies Ltd.
₹ 42.80
-5.98%
Dishman Carbogen Amcis Ltd.
₹ 184.20
-2.99%
Lasa Supergenerics Ltd.
₹ 7.65
-3.29%
Advanced Enzyme Technologies Ltd.
₹ 371.95
+1.33%
Bajaj Healthcare Ltd.
₹ 289.00
-1.53%
Ortin Global Ltd.
₹ 19.92
+9.99%
Brooks Laboratories Ltd.
₹ 67.00
+2.01%
RPG Life Sciences Ltd.
₹ 2072.00
-4.15%
Bafna Pharmaceuticals Ltd.
₹ 193.97
+10.00%
Alpa Laboratories Ltd.
₹ 68.20
-1.04%
SMS Pharmaceuticals Ltd.
₹ 366.00
-0.84%
Nectar Lifesciences Ltd.
₹ 11.72
-2.17%
By signing up I certify terms, conditions & privacy policy